BURLONE, MICHELA Emma
 Distribuzione geografica
Continente #
NA - Nord America 1.974
EU - Europa 1.727
AS - Asia 1.057
SA - Sud America 175
Continente sconosciuto - Info sul continente non disponibili 71
AF - Africa 30
OC - Oceania 1
Totale 5.035
Nazione #
US - Stati Uniti d'America 1.905
RU - Federazione Russa 419
SG - Singapore 306
IE - Irlanda 301
CN - Cina 254
IT - Italia 199
DE - Germania 197
SE - Svezia 145
FR - Francia 141
VN - Vietnam 137
BR - Brasile 134
HK - Hong Kong 131
UA - Ucraina 105
IN - India 85
GB - Regno Unito 64
FI - Finlandia 52
CA - Canada 43
BD - Bangladesh 35
KR - Corea 25
AT - Austria 24
ID - Indonesia 19
AR - Argentina 18
BE - Belgio 16
PL - Polonia 14
MX - Messico 13
ES - Italia 12
NL - Olanda 12
BJ - Benin 11
CZ - Repubblica Ceca 10
TR - Turchia 9
ZA - Sudafrica 9
EC - Ecuador 8
JP - Giappone 8
IQ - Iraq 6
IR - Iran 6
KE - Kenya 5
PH - Filippine 5
CH - Svizzera 4
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
JM - Giamaica 3
JO - Giordania 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
CO - Colombia 2
EU - Europa 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.970
Città #
Dublin 298
San Jose 246
Jacksonville 178
Hong Kong 131
Ashburn 123
Singapore 109
Chandler 89
Council Bluffs 83
Dearborn 82
Beijing 79
Ann Arbor 67
Wilmington 55
Columbus 47
Los Angeles 46
Moscow 42
Piemonte 39
Ho Chi Minh City 37
Santa Clara 37
Novara 36
Lauterbourg 34
Princeton 34
Lawrence 33
Munich 33
Buffalo 30
Hanoi 28
Seoul 25
New York 24
Phoenix 24
São Paulo 21
Frankfurt am Main 18
San Mateo 18
Milan 17
Brussels 16
Andover 14
Dallas 13
Nuremberg 13
Atlanta 12
Helsinki 12
Jakarta 12
Brooklyn 11
Cotonou 11
Denver 11
Houston 11
Toronto 11
Dong Ket 10
Turin 10
Chicago 9
Nanjing 9
Amsterdam 8
Brno 8
Falkenstein 8
Guangzhou 8
Hefei 8
Montreal 8
Orem 8
Warsaw 8
Bremen 7
Da Nang 7
London 7
Mumbai 7
Rome 7
Seattle 7
Tianjin 7
Tokyo 7
Boston 6
Hangzhou 6
Johannesburg 6
Manchester 6
Poplar 6
Redondo Beach 6
Vienna 6
Ankara 5
Augusta 5
Bexley 5
Jinan 5
Kunming 5
Nairobi 5
Porto Alegre 5
Stockholm 5
Biên Hòa 4
Boardman 4
Brasília 4
Curitiba 4
Dhaka 4
Hillsboro 4
Hải Dương 4
Leawood 4
Mexico City 4
Monmouth Junction 4
Norwalk 4
Quito 4
Rio de Janeiro 4
Shanghai 4
Turku 4
Woodbridge 4
Amman 3
Baku 3
Calgary 3
Cassano Magnago 3
Charlotte 3
Totale 2.629
Nome #
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 177
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 171
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 165
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 161
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 159
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 148
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 148
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 146
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 142
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 141
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 141
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 138
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 138
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 135
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 132
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy] 131
Influence of age on sex-related differences among patients with hepatitis C. 130
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 125
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 123
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 123
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 122
Recent advances in HCV entry 121
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 117
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 112
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 112
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 111
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 110
Interferon-stimulated gene pathways in the treatment of viral hepatitis 107
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 104
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 103
The albumin–bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development 103
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study 101
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 95
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. 93
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 92
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 89
From MASH to HCC: the role of Gas6/TAM receptors 87
Toxocara encephalitis presenting with autonomous nervous system involvement 86
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 80
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 72
PANCREATOBILIARY REFLUX RESULTING IN PANCREATIC ASCITES AND CHOLEPERITONEUM AFTER GALLBLADDER PERFORATION 72
Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis 72
Totale 5.035
Categoria #
all - tutte 23.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022186 0 0 0 18 15 2 20 12 16 22 32 49
2022/2023641 60 33 41 7 44 62 17 36 307 1 23 10
2023/2024240 24 39 21 0 35 2 42 6 1 4 27 39
2024/2025537 17 3 41 7 17 32 58 51 128 57 17 109
2025/20262.026 98 91 121 321 184 139 277 306 154 158 115 62
2026/2027467 61 156 123 127 0 0 0 0 0 0 0 0
Totale 5.035